报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 94.72% | 1.97% | 0.16% | 3/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 94.56% | 1.63% | 2.3% | 3/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 92.43% | 3.51% | -1.19% | 6/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 93.55% | 0.74% | 0.72% | 3/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 92.88% | 0.23% | -0.17% | 5/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 93.04% | 0.59% | 4.19% | 5/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 89.3% | -5.58% | -3.84% | 9/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 92.86% | -1.13% | 0.21% | 4/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 92.67% | 0.14% | 0.18% | 4/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 92.5% | -0.24% | -2.2% | 5/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 94.58% | -1.52% | 0.69% | 4/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 93.93% | -1.27% | 1.5% | 5/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 92.54% | 2% | -0.19% | 5/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 92.72% | -1.31% | -3.45% | 5/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 96.04% | 2% | 0.94% | 2/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 95.14% | 3.98% | 1.26% | 3/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-06-30 | 93.95% | 7.99% | 2.69% | 4/54 | 88.2% | 义翘神州 | 96.56% | 行业排名> |
2019-12-31 | 91.5% | 8% | 8% | 8/54 | 72.44% | 华兰疫苗 | 707.43% | 行业排名> |
2018-12-31 | 84.72% | 5.78% | -2.62% | 17/54 | 71.54% | 我武生物 | 95.6% | 行业排名> |
2018-06-30 | 87% | 7.62% | 8.62% | 5/54 | 67.2% | 我武生物 | 96.43% | 行业排名> |
2017-12-31 | 80.09% | -19.47% | -0.92% | 13/54 | -887.82% | 我武生物 | 96.51% | 行业排名> |
2017-06-30 | 80.84% | -18.67% | -18.72% | 7/54 | 63.83% | 我武生物 | 96.46% | 行业排名> |
2016-12-31 | 99.46% | 0.13% | 0.06% | 1/54 | 68.41% | 我武生物 | 96.44% | 行业排名> |
2016-06-30 | 99.4% | 2% | 0.07% | 1/54 | -3007.12% | 康辰药业 | 95.1% | 行业排名> |
2015-12-31 | 99.33% | -0.19% | -0.19% | 1/54 | 65.23% | 康辰药业 | 94.98% | 行业排名> |